RP Cure Tracker

Trials / NCT05400278

Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl Syndrome

Completed Observational Natural history / observational

Sponsor
Oslo University Hospital
Treatment
No intervention
Gene
Not stated
Conditions
Bardet-Biedl Syndrome
Ages
16 Years to 80 Years
Enrollment
30 participants
Started
2022-02-01
Main results expected
2023-03-31
Results posted
Not yet
Record last updated
2025-08-07

What the study is testing

Bardet-Biedl syndrome (BBS; OMIN #209900) is a rare genetic disorder characterized by six core features: rod-cone dystrophy (retinitis pigmentosa), polydactyly, obesity, genital anomalies, renal anomalies, and learning difficulties. This study aims to contribute to genetic and medical knowledge of BBS, and to provide information on quality of life in adults with BBS and their close relatives. Participants will undergo medical assessments (ocular, oral, and physical examinations) and self-reporting of quality of life, diet, cognitive and emotional symptoms. There are some known genotype-phenotype associations in BBS and participants will be offered genetic testing. It is important to map both genotype and associated phenotype in order to provide optimal treatment and follow-up. Individuals with BBS, age 16 years or older, will be invited to participate. The investigators expect to enroll at least 25 male and female adults with BBS and 15 of their parents to participate in qualitative interviews. These interviews will investigate parents' experiences having a child with BBS, satisfaction with health care services, experience with social and family life, and psychological health.

Where it runs

Norway (1)

Open on ClinicalTrials.gov for contacts and eligibility